alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)-alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->4)-D-Glcp

Term ID

CHEBI:68673

Synonyms

6-deoxy-alpha-L-galactopyranosyl-(1->2)-[beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->4)-D-glucopyranose
alpha-L-Fuc-(1->2)-[beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->3)]-beta-D-Gal-(1->4)-D-Glc
alpha-L-fucopyranosyl-(1->2)-[beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->4)-D-glucopyranose
alpha-L-fucosyl-(1->2)-[beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-(1->3)]-beta-D-galactosyl-(1->4)-D-glucose
Fucalpha1-2(Galbeta1-3GalNAcalpha1-3)Galbeta1-4Glc
Galb1-3GalNAca1-3(Fuca1-2)Galb1-4Glc
Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4Glc

Definition

An amino pentasaccharide comprised of a tetrasaccharide chain of β-D-galactosyl, N-acetyl-α-D-galactosaminyl, β-D-galactosyl and D-glucosyl residues linked sequentially (1→3), (1→3) and (1→4), with an α-L-fucosyl residue linked (1→2) to the galactosyl residue proximal to the reducing-end glucosyl residue.

References

glygen:G74709RD
glytoucan:G74709RD
pubmed:19443021
pubmed:31537530

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)-alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->4)-D-Glcp

Phenotype where environments contain alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)-alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->4)-D-Glcp

Phenotype modified by environments containing alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)-alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->4)-D-Glcp

Phenotype affecting alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)-alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->4)-D-Glcp

Human Disease Model